CAPTRUST Financial Advisors
JSPRW icon

CAPTRUST Financial Advisors’s Japer Therapeutics Warrants JSPRW Stock Holding History

CAPTRUST Financial Advisors’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,988
Closed -$18K – 4837
2021
Q3 		$18K Sell
11,988
-10,265
-46% -$11K ﹤0.01% 3232
2021
Q2 		$26K Sell
22,253
-2,000
-8% -$1.9K ﹤0.01% 2937
2021
Q1 		$20K Sell
24,253
-1,617
-6% -$2.37K ﹤0.01% 2999
2020
Q4 		$38K Buy
25,870
+4,200
+19% +$5.27K ﹤0.01% 1955
2020
Q3 		$25K Sell
21,670
-150
-0.7% -$152 ﹤0.01% 1877
2020
Q2 		$21K Buy
+21,820
New +$13.6K ﹤0.01% 1922

Other funds holding JSPRW

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
ICMH
Integrity Capital Management (HK) Central, Hong Kong $64K AUM
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

CAPTRUST Financial Advisors's JSPRW Position: Q4 2021 in Review

CAPTRUST Financial Advisors sold out of Japer Therapeutics Warrants (JSPRW) in Q4 2021, closing a stake of 11,988 shares — an estimated $18K sold.

CAPTRUST Financial Advisors first reported a position in JSPRW in Q2 2020 and held it in 6 quarters. The position peaked at $38K in Q4 2020. 15 funds tracked by Wall St. Rank hold JSPRW as of Q4 2021.

  • CAPTRUST Financial Advisors reported no remaining Japer Therapeutics Warrants position as of Q4 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 11,988 Japer Therapeutics Warrants shares in Q4 2021, an estimated $18K.
  • CAPTRUST Financial Advisors first reported a position in Japer Therapeutics Warrants in Q2 2020 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Japer Therapeutics Warrants position peaked at $38K in Q4 2020.
  • 15 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q4 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.